Medtronic Stock 5-Year Return: What a $10,000 MDT Investment in 2021 Became

Warren Buffett

Photo credit: commons.wikimedia.org

“I buy on the assumption that they could close the market the next day and not reopen it for five years.”

— Warren Buffett

A five-year holding period is a useful test of whether a dividend-paying stock has created value through both price performance and cash distributions. For Medtronic PLC (NYSE: MDT), a $10,000 investment made in late 2021 produced a negative total return over the subsequent five years, even with dividends reinvested. The result illustrates an important point in long-term equity analysis: a steady dividend can help cushion weaker share-price performance, but it does not fully offset a sustained decline in the stock.

MDT 5-Year Return Summary

Start date: 10/29/2021
$10,000

10/29/2021
  $9,276

10/28/2026
End date: 10/28/2026
Start price/share: $119.86
End price/share: $94.78
Starting shares: 83.43
Ending shares: 97.88
Dividends reinvested/share: $13.82
Total return: -7.23%
Average annual return: -1.49%
Starting investment: $10,000.00
Ending investment: $9,276.87

A $10,000 position in Medtronic on 10/29/2021 would have been worth $9,276.87 on 10/28/2026, assuming dividends were reinvested. That equates to a total return of -7.23% and an average annual return of -1.49%.

The arithmetic behind that outcome is straightforward. The share price fell from $119.86 to $94.78 over the period, a decline large enough to outweigh the benefit of reinvested dividends. Even though the investor’s share count rose from 83.43 shares to 97.88 shares through dividend reinvestment, the lower ending share price still left the final portfolio value below the original investment amount.

[These numbers were computed with the Dividend Channel DRIP Returns Calculator.]

What Dividend Reinvestment Changed

Dividend reinvestment improved the result, but it did not reverse it. Over the five-year period, Medtronic paid $13.82 per share in dividends, and those cash payments were assumed to be reinvested into additional MDT shares at the closing price on each ex-dividend date. That process increased ownership by more than 14 shares, which meaningfully reduced the drag from the stock’s price decline.

This is one of the clearest reasons total return matters more than price return alone when evaluating dividend stocks. A falling stock can still deliver a less severe loss, or occasionally a positive outcome, if the dividend stream is large enough and reinvestment occurs at favorable prices. In this case, however, the income component acted as a partial offset rather than a complete one.

Current Yield and Yield on Cost

Based on the most recent annualized dividend rate of $2.88 per share, MDT has a current yield of approximately 3.04% using the ending share price of $94.78. Measured against the original purchase price of $119.86, that same $2.88 annual dividend represents a yield on cost of roughly 2.54%.

These two measures answer different questions:

  • Current yield shows the dividend rate relative to the stock’s current market price.
  • Yield on cost shows the current annual dividend relative to the original purchase price.

Yield on cost can be useful for tracking how an income stream has evolved over time, but it does not replace valuation analysis. A stock purchased at a higher price may show a lower yield on cost even if its current yield has become more competitive.

How To Interpret Medtronic’s Five-Year Performance

Medtronic is widely followed as a large-cap medical technology company with an established dividend profile, so a negative five-year total return stands out. The result does not necessarily say that the business failed to generate cash or that the dividend lacked value. It indicates that the market assigned a lower valuation to the shares by the end of the period than it did at the start, and that the income received during the holding period was not sufficient to overcome that re-rating.

For long-term investors, that distinction is important. Returns are driven by three main factors:

  • Starting valuation at the time of purchase
  • Business and earnings progression over the holding period
  • Cash returned to shareholders, including dividends and their reinvestment effect

When a stock delivers a negative total return over five years despite consistent dividends, it often suggests that valuation compression or muted operational growth played a meaningful role. That is why entry price remains a central consideration even for established dividend payers.

Another great investment quote to think about:
“Behind every stock is a company. Find out what it’s doing.” — Peter Lynch